SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study
After surviving Coronavirus Disease 2019 (COVID-19), some people develop symptoms known as post-acute sequelae of COVID-19 (PASC). PASC is an emerging phenomenon yet to be fully understood, and identifying risk factors has been challenging.
|
ESWI Airborne: Intervention Strategies of Acute Respiratory Virus Infections
RSV and the bumpy road towards a vaccine
Tremendously exciting times and possibly underestimating the enormity of its impact. These are some of the comments we hear when experts share their insights on the recently available RSV vaccines.
Vaccines Europe pipeline review 2024
This report covers the period from August 2023 to August 2024, highlighting the latest developments within the vaccine industry and how these innovations are addressing existing and upcoming health threats.
Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households
Influenza vaccine effectiveness (VE) is commonly assessed against prevention of illness that requires medical attention. Few studies have evaluated VE against secondary influenza infections.
European Specialist Nurses Organisation: Video campaign on essential vaccination practices
A three-part series focusing on essential vaccination practices. It covers key aspects such as understanding vaccine protocols, ensuring proper documentation and record-keeping, and effective communication with patients.
News
Policy & Recommendations
ESWI Science Policy Interface Roundtable
Hosted by the Parliament of the Czech Republic in Prague and ESWI Board Member Roman Prymula, the event brought together key stakeholders in the Czech Republic to discuss and address the critical issues surrounding vaccine uptake.
What is the difference between monovalent and polyvalent vaccines?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Will individuals need an annual COVID-19 vaccination?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Why vaccinate from a very early age?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Can vaccinated individuals still get COVID?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Can COVID-19 vaccines be trusted when they have been developed so quickly?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Can you get influenza from the vaccine?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
